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Background
We hypothesize that T1 mapping contributes to the char-
acterization of cardiac masses based on the spectrum of
T1 relaxation times in tissue consisting of fat, calcium,
melanin, blood and simple fluid. Given the well-
established T1 lowering properties of melanin, T1mapping
may assist in the evaluation of cardiac masses in patients
with melanoma. Differentiating common cardiac tumors,
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Figure 1 A1. A DIR TSE image demonstrates fat in the atrioventricular groove as well as a non-fat-based mass at the mitral annulus. A2. The
corresponding T1 map shows a mass with a relatively low T1 value (417 ms) consistent with mitral annular calcification. B1. A DIR TSE SPAIR image
demonstrates a catheter-related thrombus in the right atrium. B2. The T1 map shows a mass with an intermediate T1 time (1114 ms). C1. An SSFP
image in a patient with metastatic melanoma demonstrates a region of bright signal intensity in the anterior myocardial segment. C2. The relatively
low T1 values (~700 ms) of the melanin-rich metastatic foci on the corresponding T1 map facilitate identification of myocardium studded with tumor.
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such as myxomas, from thrombi with T1 mapping would
also provide clinical utility, particularly in patients with a
contraindication to gadolinium.
Methods
We analyzed all CMR studies between January 2011 and
April 2014 referred to our center for mass evaluation in
patients with known metastatic melanoma, known or
suspected thrombus, myxoma, lipoma, simple cyst and
mitral annular calcification who underwent a modified
look locker inversion recovery (MOLLI) T1 mapping
sequence at 1.5T. We excluded 3 cases due to small
mass size and poor differentiation of the mass from sur-
rounding tissue. In the final analysis, we included 35 CMR
examinations from 30 individual patients. More than one
T1 measurement was performed in patients with multiple
masses or for individual masses with T1 inhomogeneity.
A total of 46 measurements were performed and averaged
according to mass type. Melanomas were further subtyped
as melanin-rich (T1 < 1000 ms) or melanin-poor
(T1 >1000 ms).
Results
Fat-based masses, melanin-rich melanomas and mitral
annular calcification showed relatively short T1 times
(Table and Figure). Conversely, thrombi and myxomas
showed intermediate and relatively long T1 times,
respectively, and the simple pericardial cyst showed the
longest T1 time (Table and Figure).
Conclusions
T1 mapping of masses may assist in tissue characteriza-
tion, particularly in melanin-rich melanomas, myxomas
and thrombi.
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Table 1 T1 Values of Cardiac Masses/Tissues
Mass/Tissue Mass/Tissue T1 Mean (ms) Mass/Tissue T1 SD (ms) CMR Examinations Patients Measurements
Fat-based 274.9 49.3 7 7 8
Calcium-based 416.9 NA 1 1 1
Melanoma (all) 893.0 237.9 11 6 17
Melanoma T1 < 1000 ms 765.2 145.4 8 3 12
Melanoma T1 > 1000 ms 1199.9 91.1 5 5 5
Thrombus 1044.7 256.9 11 11 15
Myxoma 1681.6 305.9 4 4 4
Simple pericardial cyst 3131.6 NA 1 1 1
Myocardium 1025.3 53.6 29 29 29
Epicardial fat 294.9 48.1 25 25 25
Blood 1575.2 291.5 27 27 27
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